ATHA
$3.87
Athira Pharma
($.09)
(2.27%)
ATHA
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.67)
Revenue:  N/A
Monday
Nov 14
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ATHA reports earnings?
Beat
Meet
Miss

Where is ATHA's stock price going from here?
Up
Flat
Down
Stock chart of ATHA
Analysts
Summary of analysts' recommendations for ATHA
Score
Grade
Pivots
Resistance
$4.13
$4.06
$3.97

$3.90

Support
$3.81
$3.74
$3.65
Tweet
Growth
Description
Athira Pharma Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Athira Pharma Inc. is based in SEATTLE.